Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Exicure Inc (XCUR)

Exicure Inc (XCUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement GlobeNewswire - Wed Jun 10, 3:01PM CDT

WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) (the “Company”) today announced that it received a notification letter from the Listing Qualifications Department...

XCUR : 2.20 (-8.33%)
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q GlobeNewswire - Mon Jun 1, 3:00PM CDT

REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) --  Exicure, Inc. (Nasdaq: XCUR, the “Company”)  announced today that it received a notification letter from the Listing Qualifications Department...

XCUR : 2.20 (-8.33%)
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100) GlobeNewswire - Wed Apr 22, 6:54PM CDT

CHICAGO, April 22, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) today announced that it has entered into a co-development agreement with Adbiotech Co., Ltd. (KOSDAQ: 179530), a Korea-based biotechnology...

XCUR : 2.20 (-8.33%)
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions GlobeNewswire - Thu Apr 2, 3:01PM CDT

REDWOOD CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today released the following...

XCUR : 2.20 (-8.33%)
Exicure, Inc. Reports Full Year 2025 Financial Results GlobeNewswire - Wed Mar 25, 3:18PM CDT

REDWOOD CITY, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR, the “Company”) releases the following financial results for the year ended December 31, 2025. 2025 Financial...

XCUR : 2.20 (-8.33%)
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant GlobeNewswire - Thu Feb 5, 6:00AM CST

REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication...

XCUR : 2.20 (-8.33%)
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings GlobeNewswire - Wed Jan 21, 6:00AM CST

REDWOOD CITY, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it...

XCUR : 2.20 (-8.33%)
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting GlobeNewswire - Mon Dec 8, 2025

REDWOOD CITY, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced positive...

XCUR : 2.20 (-8.33%)
Exicure, Inc. Reports Third Quarter 2025 Financial Results GlobeNewswire - Fri Nov 7, 2025

REDWOOD CITY, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR, the “Company”) releases the following financial results for the fiscal quarter ended September 30, 2025. ...

XCUR : 2.20 (-8.33%)
New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting GlobeNewswire - Mon Nov 3, 2025

REDWOOD CITY, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that results...

XCUR : 2.20 (-8.33%)

Barchart Exclusives

This Lesser-Known Dividend Stock Is Beating the S&P 500 in 2026 and Yields More Than 3% Barchart - 22 minutes ago
Watsco has raised its quarterly dividend by 10% to $3.30 per share, lifting the annualized payout to $13.20 and delivering a forward yield above 3%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.